Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. (Q44598571)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14512873%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14512873%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

0 references

0 references

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14512873%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

author name string

David R Nelson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14512873%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Consuelo Soldevila-Pico

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14512873%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Manal Abdelmalek

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14512873%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Haizhen Zhu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14512873%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Yi Ling Xu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14512873%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Roniel Cabrera

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14512873%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Chen Liu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14512873%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Gary L Davis

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14512873%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

language of work or name

English

0 references

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14512873%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14512873%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14512873%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14512873%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

859-868

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14512873%20AND%20SRC:MED&resulttype=core&format=json

Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection

19 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Effect of alpha interferon on the hepatitis C virus replicon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Endogenous interleukin-10 is required for prevention of a hyperinflammatory intracerebral immune response in Listeria monocytogenes meningoencephalitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

The role of IL-10 in promoting disease progression in leishmaniasis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Analysis of a successful immune response against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Relationship between interferon-gamma, interleukin-10, and interleukin-12 production in chronic hepatitis C and in vitro effects of interferon-alpha

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Interleukin-10 and the interleukin-10 receptor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Regulatory role of T cells producing both interferon gamma and interleukin 10 in persistent infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Regulatory T cells: key controllers of immunologic self-tolerance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021

Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380412

7 January 2021